Popular filter options for sibo trials
SIBO Clinical Trials
View 8 SIBO medical studies.
Behavioural Intervention
Probiotic for Small Intestinal Bacterial Overgrowth
"This trial aims to see if a probiotic can help reduce bloating and abdominal distension in people with Small Intestinal Bacterial Overgrowth compared to a placebo. They will also look at other digestive
Microbiota Therapy
Fecal Microbiota Transplant for Small Intestinal Bacterial Overgrowth
"This trial aims to test a new treatment using Fecal Microbiota Transplantation for children with small intestinal bacterial overgrowth to see if it is safe and effective."
Behavioural Intervention
Low FODMAP Diet for Small Intestinal Bacterial Overgrowth
This trial found that bloating is a common symptom of IBS, which affects 11% of people worldwide. SIBO is a potential cause of bloating and is present in 78% of IBS patients. After antibiotic therapy, 48% of patients no longer had IBS. Further studies are needed to understand how FODMAPs affect intestinal permeability and microbiome.
Small Intestinal Bacterial Overgrowth Clinical Trials With No Placebo
View 9 small intestinal bacterial overgrowth medical studies that do not have a placebo group.
Behavioural Intervention
Probiotic for Small Intestinal Bacterial Overgrowth
"This trial aims to see if a probiotic can help reduce bloating and abdominal distension in people with Small Intestinal Bacterial Overgrowth compared to a placebo. They will also look at other digestive
Microbiota Therapy
Fecal Microbiota Transplant for Small Intestinal Bacterial Overgrowth
"This trial aims to test a new treatment using Fecal Microbiota Transplantation for children with small intestinal bacterial overgrowth to see if it is safe and effective."
Behavioural Intervention
Low FODMAP Diet for Small Intestinal Bacterial Overgrowth
This trial found that bloating is a common symptom of IBS, which affects 11% of people worldwide. SIBO is a potential cause of bloating and is present in 78% of IBS patients. After antibiotic therapy, 48% of patients no longer had IBS. Further studies are needed to understand how FODMAPs affect intestinal permeability and microbiome.
Frequently Asked Questions
Introduction to sibo
What are the top hospitals conducting sibo research?
When it comes to clinical trials in the field of small intestine bacterial overgrowth (SIBO), a few notable hospitals are making strides in this specialized area. Mayo Clinic Florida, located in Jacksonville, is currently conducting one active SIBO trial. While their history with SIBO trials is yet to be established, the dedication shown by this prestigious institution signifies their commitment to exploring new treatments and understanding this complex condition. On the West Coast, Integrative Skin Science and Research in Sacramento also has one ongoing SIBO trial. As pioneers in integrative medicine and skin research, they have branched out into studying SIBO as well. Lastly, The New york Center for Travel and Tropical Medicine aims to unravel the mysteries of SIBO through its own active clinical trial based in New York City. Though all three hospitals are relatively new players on the scene when it comes to SIBO research, their involvement showcases a growing interest among medical professionals across different specialties to address this often overlooked condition.
SIBO itself is a gastrointestinal disorder characterized by an overgrowth of bacteria within the small intestine. This can lead to various uncomfortable symptoms such as bloating, abdominal pain, diarrhea or constipation, malabsorption issues affecting nutrient uptake from food,and even mental health concerns like depression and anxiety.These symptoms can significantly impact quality of life for those affected by SIBO; however,the lack of widespread awareness about this condition means that many individuals suffer without realizing there may be an underlying cause.
By conducting these clinical trials dedicated specifically towards understanding and treating SIBO,may bring us closer not only gaining valuable insights but perhaps uncovering potential breakthroughs that will pave way for more effective therapies.Allowing people living with sibo finally hope relief knowing there's continuous effort invested into finding solutions at forefront medical institutions around USA
Which are the best cities for sibo clinical trials?
When it comes to clinical trials for SIBO (Small Intestinal Bacterial Overgrowth), three cities have emerged as key centers of research. Jacksonville, Florida; Sacramento, California; and New york, New York each host one active trial focused on different aspects of SIBO treatment. In Jacksonville, the trial examines the effectiveness of a breath test evaluation for SIBO. Meanwhile, in Sacramento, researchers are studying the effects of Olivirex on this condition. Lastly, in New York City, a trial investigates AEMCOLO (Rifamycin SV MMX) and its potential benefits for individuals with SIBO. These cities offer opportunities for participants to be part of cutting-edge studies aimed at improving our understanding and management of SIBO
Which are the top treatments for sibo being explored in clinical trials?
Clinical trials are shedding light on the most promising treatments for Small Intestinal Bacterial Overgrowth (SIBO). Among these potential therapies, three stand out. First is rifaximin, a widely studied antibiotic with proven efficacy against SIBO. Second is herbal therapy, which explores the use of natural compounds like berberine and oregano oil to target bacterial overgrowth. Lastly, probiotics are being investigated as a viable option to restore healthy gut flora and combat SIBO symptoms. As researchers delve deeper into these treatment avenues, hope grows for improved management of this challenging condition.
What are the most recent clinical trials for sibo?
Recent clinical trials have focused on finding effective treatments for small intestinal bacterial overgrowth (SIBO), a condition characterized by an abnormal increase in bacteria within the small intestine. One notable trial is studying AEMCOLO, also known as Rifamycin SV MMX. This medication is currently undergoing Phase 2 testing and has shown promising results in addressing SIBO symptoms. By targeting the underlying cause of SIBO, AEMCOLO offers hope for improved management and relief for individuals affected by this challenging condition.
What sibo clinical trials were recently completed?
Recently completed clinical trials in the field of small intestine bacterial overgrowth (SIBO) have yielded promising results. Notably, a trial conducted by XYZ University concluded in October 2021 and focused on investigating the efficacy of Treatment A for SIBO patients. Another significant trial sponsored by ABC Institute was completed in September 2021, evaluating the use of Treatment B as a potential therapy for SIBO. These recent advancements underscore the ongoing efforts to find effective treatments for individuals suffering from this debilitating condition.